Guardant in the News
Achieving Diversity in Clinical Trials: Charting a More Equitable Path for Research
One year ago, President Biden reinstated the Cancer Moonshot to reduce the nation’s cancer burden and shed light on inequities in cancer care, calling on both the public and private sectors to help meet this challenge. One area where industry can take initiative is ensuring research and clinical trials capture a diverse patient population.
How Guardant is Redefining Cancer Detection
Guardant Health Scaling Up in San Diego
Close the Gap: Disparities in Cancer Screening Threaten Lives
February marks National Cancer Prevention Month, an initiative to bring awareness to ways Americans can reduce their risk for cancer. While more than 1.7 million Americans will be diagnosed with cancer this year, research suggests that up to 50 percent of cases – and 50 percent of deaths – are preventable. That’s why one key recommendation is to get regular cancer screenings.
Precision Medicine is Transforming Cancer Care
How sophisticated technology and personalized treatment options are enabling more people with advanced cancer to manage and live with their diagnoses for the long-term.
Using Data to Conquer Cancer
Helmy Eltoukhy stops by The Morning Fix by 510k Café podcast to discuss the technologies Guardant Health is developing for patients with early and late-stage cancers. We also discuss the Clear Your View campaign, which raises awareness of the essential role complete biomarker testing plays in guiding initial treatment decisions for patients with advanced solid tumor cancers, including colorectal and lung cancers.
The Promise of Cancer Screening: Screen for Cancers Where Lives Can be Saved
Innovations in cancer therapeutics and precision diagnostics impact countless lives as more and more cancer patients are able to claim the title of cancer survivor. While we applaud this progress, for too many patients innovation has not won out over disease.
Disparities in clinical trials threaten African American lives
On World Cancer Research Day, we must correct course